Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 1
1949 2
1950 3
1952 2
1953 4
1955 2
1956 2
1957 3
1958 1
1959 2
1960 1
1962 2
1963 1
1964 1
1966 1
1967 1
1970 1
2004 1
2014 1
2018 1
2021 3
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of CARVYKTI in CARTITUDE-4 versus other conventional treatment regimens for lenalidomide-refractory multiple myeloma using inverse probability of treatment weighting.
Alsdorf W, Diels J, Ghilotti F, Mendes J, Hernando T, Cost P, Schecter JM, Lendvai N, Patel N, Triguero A, Ursi M. Alsdorf W, et al. Among authors: hernando t. J Comp Eff Res. 2024 Sep;13(9):e240080. doi: 10.57264/cer-2024-0080. Epub 2024 Aug 20. J Comp Eff Res. 2024. PMID: 39162049 Free PMC article. Clinical Trial.
Comparative efficacy of ciltacabtagene autoleucel versus idecabtagene vicleucel in the treatment of patients with relapsed or refractory multiple myeloma previously treated with 2-4 prior lines of therapy: a matching-adjusted indirect comparison.
Bar N, Diels J, van Sanden S, Mendes J, Hernando T, Burnett H, Cost P, Schecter JM, Lendvai N, Patel N, Ishida T, Er J, Harrison SJ, Lopez-Muñoz N. Bar N, et al. Among authors: hernando t. Curr Med Res Opin. 2024 Sep;40(9):1597-1603. doi: 10.1080/03007995.2024.2391112. Epub 2024 Aug 22. Curr Med Res Opin. 2024. PMID: 39129504
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison.
Puig N, Diels J, van Sanden S, Mendes J, Burnett H, Cichewicz A, Lee S, Hernando T, Schecter JM, Lendvai N, Patel N, Sanchez-Pina JM, Rocchi S, Mina R, Corradini P, Cavo M, Miguel JS, Shune L, Khan AM, Sidana S, Leleu X, Manier S, Lipe B, Weisel K, Martinez-Lopez J. Puig N, et al. Among authors: hernando t. Adv Ther. 2025 Jul;42(7):3223-3239. doi: 10.1007/s12325-025-03205-8. Epub 2025 May 12. Adv Ther. 2025. PMID: 40354013 Free PMC article. Clinical Trial.
Spanish consensus on the physical health of patients with depressive disorders.
Giner J, Saiz Ruiz J, Bobes J, Zamorano E, López F, Hernando T, Rico-Villademoros F, Álamo C, Cervilla JA, Ibáñez Cuadrado Á, Ibáñez Guerra E, López S, Morán P, Palao DJ, Romacho M; Development Group Recommendations on Physical Health in Patients with Depression. Giner J, et al. Among authors: hernando t. Rev Psiquiatr Salud Ment. 2014 Oct-Dec;7(4):195-207. doi: 10.1016/j.rpsm.2014.05.003. Epub 2014 Jul 30. Rev Psiquiatr Salud Ment. 2014. PMID: 25087131 English, Spanish.
[Intestinal tuberculosis].
HERNANDO T. HERNANDO T. Rev Esp Enferm Apar Dig Nutr. 1949 Jan-Feb;8(1):95-128. Rev Esp Enferm Apar Dig Nutr. 1949. PMID: 18117075 Spanish. No abstract available.
[Intestinal tuberculosis].
HERNANDO T. HERNANDO T. Medicamenta (Madr). 1947 Nov 16;5(137):265-7. Medicamenta (Madr). 1947. PMID: 18857277 Spanish. No abstract available.
[Doctor MARANON].
HERNANDO T. HERNANDO T. Prog Ter Clin. 1960 Apr;13:v-viii. Prog Ter Clin. 1960. PMID: 14042297 Spanish. No abstract available.
[Precancerous diseases].
HERNANDO T. HERNANDO T. Rev Esp Enferm Apar Dig Nutr. 1952 May-Jun;11(3):815-36. Rev Esp Enferm Apar Dig Nutr. 1952. PMID: 13014523 Undetermined Language. No abstract available.
Optimal treatment sequencing of abiraterone acetate plus prednisone and enzalutamide in patients with castration-resistant metastatic prostate cancer: A systematic review and meta-analysis.
Cassinello J, Domínguez-Lubillo T, Gómez-Barrera M, Hernando T, Parra R, Asensio I, Casado MA, Moreno P. Cassinello J, et al. Among authors: hernando t. Cancer Treat Rev. 2021 Feb;93:102152. doi: 10.1016/j.ctrv.2020.102152. Epub 2021 Jan 11. Cancer Treat Rev. 2021. PMID: 33486302
40 results